Nav: Home

Mammography screening: Only 1 in 3 women is well-informed

November 04, 2015

Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision. These are the results of a study that health care researchers at Bielefeld University are publishing today (03.11.2015) in the international specialist journal PLOS ONE. 'Further information and support services are needed to spread more knowledge about the programme - especially to women with little education and women with a Turkish migration background,' sums up Junior professor Jacob Spallek, who ran the study together with Professor Petra Kolip.

The mammography screening programme (MSP) is open for all women in Germany over the age of 50. It can help detect and therefore treat breast cancer at an early stage. However, because not every screening delivers a clear outcome, mistakes can sometimes lead to false diagnoses, overtreatment, or stress. Jacob Spallek says, 'That is why every woman should take care to find out about the risks and the benefits before accepting the invitation to attend mammography screening.' The researchers have studied how much women know about the screening and how they then decide in favour of or against it.

Breast cancer is the most frequent type of cancer among women. Early diagnosis through MSP can help to lower the mortality rate. Every two years, women aged between 50 and 69 years are invited to attend MSP. Nonetheless, there is controversy over whether the potential disadvantages of screening possibly outweigh the advantages. This is why the concept of 'informed choice' has become increasingly more important in the health sciences. It states that whoever has sufficient knowledge about a proposal can form her own opinion about it and make a conscious choice. The goal of the research project was to describe which proportion of women in general and which proportion of women with a Turkish migration background decide in favour of or against MSP - and also make an informed choice. 'For the result, it didn't matter whether the choice was for or against the screening,' Spallek explains. 'The only thing that was important was whether the decision was based on sufficient information.'

Participants were approximately 5,000 women in the Westphalia-Lippe region who were invited to attend an MSP for the first time. A total of 27.1 per cent of the invited women made an informed choice for or against participating in the MSP. Whereas 28.2 per cent of the women with no migration background made an informed choice, this was 21.8 per cent among ethnic German immigrants [Spätaussiedlerinnen] and 20.0 per cent among women with other countries of origin. The lowest proportion of informed decisions came from women with a Turkish migration background at 5.0 per cent. 'In sum, there is room for improvement in the proportion of informed choices when it comes to MSP in Germany,' concludes Jacob Spallek.
Original publication: Berens, Eva-Maria; Reder, Maren; Razum, Oliver; Kolip, Petra; Spallek, Jacob (2015) Informed choice in the German mammography screening program by education and migrant status: survey among first-time invitees. PLOS ONE. Nov 3. Doi: 10.1371/journal.pone.0142316

Contact: Jun.-Prof. Dr. Jacob Spallek, Bielefeld University
Faculty of Health Sciences, AG 3 Epidemiology & International Public Health
Telephone: 0521 106-2554

Eva-Maria Berens, Bielefeld University
Faculty of Health Sciences, AG 6 Public Health Nursing & Health Science Research
Telephone: 0521 106-4818

Bielefeld University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".